Novo Integrated Sciences Stock Target Price
| NVOSDelisted Stock | USD 0.04 0.01 17.57% |
Novo Integrated Sciences fundamentals help investors to digest information that contributes to Novo Integrated's financial success or failures. It also enables traders to predict the movement of Novo OTC Stock. The fundamental analysis module provides a way to measure Novo Integrated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novo Integrated otc stock.
Novo |
Novo Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in target price category among its peers.
Novo Fundamentals
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (1.80) % | ||||
| Operating Margin | (0.80) % | ||||
| Current Valuation | 5.8 M | ||||
| Shares Outstanding | 19.05 M | ||||
| Shares Owned By Insiders | 6.82 % | ||||
| Shares Owned By Institutions | 5.77 % | ||||
| Number Of Shares Shorted | 274.86 K | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 12.57 M | ||||
| Gross Profit | 3.82 M | ||||
| EBITDA | (5.63 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.47 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (0.41) X | ||||
| Number Of Employees | 127 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 2.84 M | ||||
| Total Asset | 35.56 M | ||||
| Retained Earnings | (67.03 M) | ||||
| Working Capital | (3.52 M) | ||||
| Net Asset | 35.56 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Integrated Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Novo OTC Stock
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |